Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Apixaban
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Anticoagulants
- ATC
- B01AF
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Pack
- 30
- Registration no.
- 104681
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Apiban (Apixaban) is used for
Apixaban is an anticoagulant, often called a blood thinner. It blocks a protein called factor Xa that the body needs to make clots, so it helps stop harmful clots forming. It does not break down clots that already exist. It is a prescription-only medicine and comes as tablets.
- Preventing stroke and other clot-related blockages in adults with atrial fibrillation (an irregular heartbeat) who have another risk factor
- Treating deep vein thrombosis (a clot in a leg vein) and pulmonary embolism (a clot in the lungs), and helping stop them coming back
- Preventing clots in the leg veins after a hip or knee replacement operation
- Treating clots in some children, as decided by a specialist
Get medical help straight away if
- Go to the emergency department or call an ambulance for heavy bleeding that will not stop, vomiting or coughing up blood (or material like coffee grounds), red or black tarry stools, or pink, red or brown urine.
- Get emergency help after a head injury or a bad fall, even if you feel well, because bleeding inside the head can happen. Do not drive yourself.
- Get emergency help for a sudden severe headache, vision changes, fits (seizures), or numbness, weakness or signs of a stroke.
- Get emergency help for signs of a serious allergic reaction: swelling of the face, lips, mouth, tongue or throat, wheezing, trouble breathing, or feeling faint.
Side effects, warnings and interactions for Apixaban
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Apixaban
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Apixaban is right for you and the dose.
- Atrial fibrillation: first choice to prevent stroke when stroke risk is raised
- Stroke: for people whose stroke was caused by atrial fibrillation
About Apiban 2.5 mg tablet
Apiban 2.5 mg tablet contains Apixaban 2.5 mg. It is registered with DRAP by Highnoon Laboratories Ltd (registration no. 104681). Its official price is PKR 3,522.09 for a pack of 30, about PKR 117.40 per tablet. This price has applied since 27 July 2026. Apiban is also available as 5 mg tablet. 13 other brands of Apixaban 2.5 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Other strengths of Apiban
All 13 other brands of Apixaban 2.5 mg tablet in Pakistan
These 13 brands are alternatives (substitutes) to Apiban: each contains Apixaban 2.5 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Apibosh (Bosch Pharmaceuticals (Pvt) Ltd) at PKR 103 per tablet; the highest is Eliquis s at PKR 164. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Apibosh | Bosch Pharmaceuticals (Pvt) Ltd | 30's | PKR 3,098.63 | PKR 103 / tablet |
| Pixcito | NovaMed Pharmaceuticals(Pvt.)Ltd | 30's | PKR 3,098.63 | PKR 103 / tablet |
| Advaxaban | Martin Dow Marker Limited | 30's | PKR 3,315.53 | PKR 111 / tablet |
| HILAPIX | Hilton Pharma (Pvt) Limited | 30's | PKR 3,315.54 | PKR 111 / tablet |
| Apixion | Pinnacle Biotech (Pvt.) Ltd | 30's | PKR 3,356.29 | PKR 112 / tablet |
| Apixaget | Getz Pharma (Pvt) Limited | 30's | PKR 3,356.30 | PKR 112 / tablet |
| Cloxipa | Nabiqasim Industries (Pvt) Ltd | 30's | PKR 3,418.99 | PKR 114 / tablet |
| Zilero | PHARMEVO (PVT) LTD | 30's | PKR 3,440.65 | PKR 115 / tablet |
| Abaxil2.5mg | Saffron Pharmaceuticals | 30's | PKR 3,522.09 | PKR 117 / tablet |
| ELIXABAN | Martin Dow Limited | 30's | PKR 3,522.10 | PKR 117 / tablet |
| Platixa | Pharmatec Pakistan (Pvt.) Limited | 10's | PKR 1,203.03 | PKR 120 / tablet |
| Ecru | Scotmann Pharmaceuticals | 30's | PKR 4,333.93 | PKR 144 / tablet |
| Eliquis s | Pfizer Pakistan Limited | 10's | PKR 1,644.35 | PKR 164 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Apiban, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Highnoon Laboratories Ltd, Lahore
- DRAP registration
- 104681
- Phone
- +92 42 111 000 465
- info@highnoon.com.pk
- Website
- https://highnoon-labs.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (30). Current price PKR 3,522.09, effective 27 Jul 2026.
Cite this price history
MedInfoBase. Apiban 2.5 mg, 30: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/apiban-2-5-mg-104681-30-highnoon-laboratories-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 3,522.09 | 2026-07-27 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 104681Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.